Tumor-specific novel taxoid-monoclonal antibody conjugates

Journal of Medicinal Chemistry

Volumn 45, Issue 26, 2002, Pages 5620-5623

  Ojima, Iwao ^a   Geng, Xudong ^a   Wu, Xinyuan ^a   Qu, Chuanxing ^a   Borella, Christopher P ^a   Xie, Hongsheng ^b   Wilhelm, Sharon D ^b   Leece, Barbara A ^b   Bartle, Laura M ^b   Goldmacher, Victor S ^b   Chari, Ravi V J ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b IMMUNOGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PACLITAXEL; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOCONJUGATES; MICE; MICE, SCID; PACLITAXEL; PRODRUGS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037137606     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm025540g     Document Type: Article

References (27)

1. Chari, R. V. J. Targeted delivery of chemotherapeutics: Tumor-activated prodrug therapy. Adv. Drug Delivery Rev. 1998, 31, 89-104.
2. Liu, C. N.; Tadayoni, B. M.; Bourret, L. A.; Mattocks, K. M.; Derr, S. M.; Widdison, W. C.; Kedersha, N. L.; Ariniello, P. D.; Goldmacher, V. S.; Lambert, J. M.; Blattler, W. A.; Chari, R. V. J. Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 8618-8623.
3. Chari, R. V. J.; Jackel, K. A.; Bourret, L. A.; Derr, S. M.; Tadayoni, B. M.; Mattocks, K. M.; Shah, S. A.; Liu, C. N.; Blattler, W. A.; Goldmacher, V. S. Enhancement of the selectivity and antitumor efficacy of a CC-1065 analog through immunoconjugate formation. Cancer Res. 1995, 55, 4079-4084.
4. Sunada, H.; Magun, B. E.; Mendelsohn, J.; MacLeod, C. L. Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 3825-3829.
5. Vollmar, A. M.; Bunker, D. E.; Mendelsohn, J.; Herschman, H. R. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor. J. Cell Physiol. 1987, 131, 418-425.
6. 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor. Cancer Res. 1992, 52, 121-126.
7. Hamaan, P. R.; Hinman, L. M.; Hollander, I.; Beyer, C. F.; Lindh, D.; Holcomb, R.; Hallett, W.; Tsou, H.-H.; Upeslacis, J.; Shochat, D.; Mountain, A.; Flowers, D. A.; Bernstein, I. Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjugate Chem. 2002, 13, 47-58.
8. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of microbubule assembly in vitro by taxol. Nature 1979, 277, 665-667.
9. Guillemard, V.; Saragovi, H. U. Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity. Cancer Res. 2001, 61, 694-699.
10. Jaime, J.; Page, M. Paclitaxel immunoconjugate for the specific treatment of ovarian cancer in vitro. Anticancer Res. 2001, 21, 1119-1128.
11. Ojima, I.; Kuduk, S. D.; Chakravarty, S. In Advances in Medicinal Chemistry; Maryanoff, B. E., Reitz, A. B., Eds.; JAI Press: Greenwich, CT, 1998; Vol. 4, pp 69-124.
12. Ojima, I.; Lin, S.; Wang, T. The recent advances in the medicinal chemistry of taxoids with novel β-amino acid side chains. Curr. Med. Chem. 1999, 6, 927-954.
13. Ojima, I.; Slater, J. C.; Michaud, E.; Kuduk, S. D.; Bounaud, P.-Y.; Vrignaud, P.; Bissery, M.-C.; Veith, J.; Pera, P.; Bernacki, R. J. Syntheses and structure-activity relationships of the second generation antitumor taxoids. Exceptional activity against drug-resistant cancer cells. J. Med. Chem. 1996, 39, 3889-3896.
14. Ojima, I.; Slater, J. S.; Kuduk, S. D.; Takeuchi, C. S.; Gimi, R. H.; Sun, C.-M.; Park, Y. H.; Pera, P.; Veith, J. M.; Bernacki, R. J. Syntheses and structure-activity relationships of taxoids derived from 14β-hydroxy-10-deacetylbaccatin III. J. Med. Chem. 1997, 40, 267-278.
15. Ojima, I.; Kuduk, S. D.; Pera, P.; Veith, J. M.; Bernacki, R. J. Synthesis of and structure-activity relationships of non- aromatic taxoids. Effects of alkyl and alkenyl ester groups on cytotoxicity. J. Med. Chem. 1997, 40, 279-285.
16. Ojima, I.; Lin, S. Efficient asymmetric syntheses of β-lactams bearing a cyclopropane or an epoxide moiety and their application to the syntheses of novel isoserines and taxoids. J. Org. Chem. 1998, 63, 224-225.
17. Ojima, I.; Wang, T.; Miller, M. L.; Lin, S.; Borella, C. P.; Geng, X.; Pera, P.; Bernacki, R. J. Syntheses and structure-activity relationships of new second-generation taxoids. bioorg. Med. Chem. Lett. 1999, 9, 3423-3428.
18. Lin, S.; Geng, X.; Qu, C.; Tynebor, R.; Gallagher, D. J.; Polina, E.; Rutter, J.; Ojima, I. Synthesis of highly potent second-generation taxoids through effective kinetic resolution coupling of racemic β-lactams with baccatins. Chirality 2000, 12, 431-441.
19. Holton, R. A.; Biediger, R. J.; Boatman, P. D. In Taxol: Science and Applications; Suffness, M., Ed.; CRC Press: New York, 1995; pp 97-121.
20. Ojima, I.; Habus, I.; Zhao, M.; Zucco, M.; Park, Y. H.; Sun, C. M.; Brigaud, T. New and efficient approaches to the semisynthesis of taxol and its C-13 side-chain analogs by means of beta-lactam synthon method. Tetrahedron 1992, 48, 6985-7012.
21. Ojima, I.; Duclos, O.; Zucco, M.; Bissery, M.-C.; Combeau, C.; Vrignaud, P.; Riou, J. F.; Lavelle, F. Synthesis and structure- activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3′ and/or C-2 of taxoteμre (Docetaxel). J. Med. Chem. 1994, 37, 2602-2608.
22. Ojima, I.; Duclos, 0.; Kuduk, S. D.; Sun, C.-M.; Slater, J. C.; Lavelle, F.; Veith, J. M.; Bernacki, R. J. Synthesis and biological activity of 3′-alkyl- and 3′-alkenyl-3′-dephenyldocetaxels. Bioorg. Med. Chem. Lett. 1994, 4, 2631-2634.
23. Datta, A.; Hepperle, M.; Georg, G. I. Selective deesterification studies on taxanes. Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities. J. Org. Chem. 1995, 60, 761-763.
24. Chari, R. V. J.; Goldmacher, V. S.; Lambert, J. M.; Blattler, W. A. Cytotoxic Agents Comprising Maytansinoids and their Therapeutic Use. U.S. Patent 5,208,020, 1993.
25. Kingston, D. G. I.; Chaudhary, A. G.; Chordia, M. D.; Gharpure, M.; Gunatilaka, A. A. L.; Higgs, P. I.; Rimoldi, J. M.; Samala, L.; Jagtap, P. G.; Giannakakou, P.; Jiang, Y. Q.; Lin, C. M.; Hamel, E.; Long, B. H.; Fairchild, C. R.; Johnston, K. A. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol). J. Med. Chem. 1998, 41, 3715-3726.
26. Chen, S. H.; Kant, J.; Mamber, S. W.; Roth, G. P.; Wei, J. M.; Marshall, D.; Vyas, D. M.; Farina, V.; Casazza, A.; Long, B. H.; Rose, W. C.; Johnston, K.; Fairchild, C. Taxol structure-activity relationships-synthesis and biological evaluation of taxol analogs modified at C-7. Bioorg. Med. Chem. Lett. 1994, 4, 2223-2228.
27. Han, J.-w.; Dionne, C. A.; Kedersha, N. L.; Goldmacher, V. S. Status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc. Cancer Res. 1997, 57, 176-182.